7:01 AM ET
8-K
Stock Buyback
United Therapeutics Announces $2B Stock Buyback
United Therapeutics' Board of Directors authorized a new $2.0 billion share repurchase program for its common stock. The authorization is effective for one year through October 21, 2027, and allows for repurchases via open market transactions, accelerated share repurchase programs, or private deals.
- Value
- $2B
- Term
- 1 year